Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
27.84
-0.83 (-2.90%)
At close: Mar 13, 2026, 4:00 PM EDT
27.91
+0.07 (0.25%)
After-hours: Mar 13, 2026, 7:05 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.33 billion as of March 13, 2026. Its market cap has increased by 238.71% in one year.
Market Cap
1.33B
Enterprise Value
851.50M
1-Year Change
238.71%
Ranking
Category
Stock Price
$27.84
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.33B, an increase of 121.24%. That is a compound annual growth rate of 56.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.33B | -7.97% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.42B |
| Trevi Therapeutics | 1.41B |
| Capricor Therapeutics | 1.39B |
| Pharvaris | 1.39B |
| AtaiBeckley | 1.34B |
| MBX Biosciences | 1.33B |
| Vir Biotechnology | 1.29B |
| Zenas BioPharma | 1.29B |